Evidence map›Paper›PMID 38107056›Full record

ArticleMedComm2023

FOXC1 restrains NF-κB-mediated interleukin-1β transcription in breast cancer.

Yan Liu, Shuang Chen, Mao Tian, Armando Giuliano, Xiaojiang Cui

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in MedComm, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Protective Role of Rosmarinic Acid-EnrichedBiochemistry research international · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yan LiuDepartment of Surgery Cedars-Sinai Medical Center Los Angeles California USA.
Shuang ChenDepartment of Biomedical Sciences Cedars-Sinai Medical Center Los Angeles California USA.
Mao TianJonsson Comprehensive Cancer Center The University of California Los Angeles California USA.
Armando GiulianoDepartment of Surgery Cedars-Sinai Medical Center Los Angeles California USA.
Xiaojiang CuiDepartment of Surgery Cedars-Sinai Medical Center Los Angeles California USA.ORCID https://orcid.org/0000-0002-6843-736X
Cedars-Sinai Medical Center · USUniversity of California, Los Angeles · US

Funding

The Role of FOXCI in Basal-like Breast CancerR01CA151610 · NCI · SAINT JOHN'S CANCER INSTITUTE · PI CUI, XIAOJIANG · 2011 to 2022
$3.8M
Crosslinking-based targeted therapy for triple-negative breast cancerR21CA280458 · NCI · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI CHEN, SHENGXI, CUI, XIAOJIANG · 2023 to 2024
$418k
NCI NIH HHS R01 CA151610NCI NIH HHS R21 CA280458
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38107056
PMCPMC10725083
OpenAlexW4389833606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.